Zobrazeno 1 - 10
of 13
pro vyhledávání: '"D G, Soldatov"'
Publikováno v:
PULMONOLOGIYA. 33:129-131
Publikováno v:
PULMONOLOGIYA. 30:561-568
The high informative value of chest computed tomography in the diagnosis of pneumonia caused by SARS-CoV-2 is generally recognized, but there is no enough data on the diagnostic capabilities of this method within 5 first days of the clinical manifest
Autor:
L I Alekseeva, G S Arkhangelskaya, A F Davydova, E A Karmiltseva, К М Kogan, V I Mazurov, A P Rebrov, O F Ryabitseva, T G Shemerovskaya, S S Yakushin, V A Nasonova, D G Soldatov
Publikováno v:
Терапевтический архив, Vol 78, Iss 9, Pp 82-86 (2003)
Aim. To evaluate duration of a clinical response to the drug structum in patients with osteoarthrosis (OA) of the knee and hip joints as well as structum effects on OA course and that of concomitant diseases. Material and methods. The duration of a c
Externí odkaz:
https://doaj.org/article/f2dd9ee88dcc4eefbba4757b56c5423e
Publikováno v:
Терапевтический архив, Vol 79, Iss 11, Pp 93-95 (2004)
Aim. To study efficacy of the chondroprotector chondroitin sulphate (structum, Pier Fabr Medicament Production, France) in patients with rheumatoid arthritis (RA) and secondary osteoarthrosis of the knee joints. Material and methods. 15 women with a
Externí odkaz:
https://doaj.org/article/26ed4dbfca94481db5436ad602b16e76
Publikováno v:
Terapevticheskii arkhiv. 79(1)
To evaluate long-term therapeutic effect and safety of structum in patients with manifest coxarthrosis.Twenty patients with manifest coxarthrosis of degree I-III were given a 6 month structum course. Criteria of efficacy were Leken index, pain in the
Publikováno v:
Terapevticheskii arkhiv. 76(11)
To study efficacy of the chondroprotector chondroitin sulphate (structum, Pier Fabr Medicament Production, France) in patients with rheumatoid arthritis (RA) and secondary osteoarthrosis of the knee joints.15 women with a long history of RA (mean dur
Publikováno v:
Terapevticheskii arkhiv. 73(11)
To study cost-effect efficiency of structum in patients with knee and hip joint osteoarthrosis (OA) in a multicenter trial.The trial enrolled 192 patients with OA. 110 patients had knee joint OA and 82 patients hip joint OA. The patients received str
Autor:
D G, Soldatov
Publikováno v:
Terapevticheskii arkhiv. 67(3)
Autor:
A G, Chuchalin, D G, Soldatov
Publikováno v:
Terapevticheskii arkhiv. 64(3)
Autor:
D G, Soldatov
Publikováno v:
Terapevticheskii arkhiv. 62(8)